Literature DB >> 7886404

Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.

M Tanaka1, A Maruoka, Y Chijiiwa, M Tanaka1, H Nawata.   

Abstract

BACKGROUND: It has been reported that time to peptic ulcer healing is shorter with proton pump inhibitors (PPI) than with H2-receptor antagonists (H2-RA). This study was designed to examine the difference in the healing process between gastric ulcers treated with PPI and those treated with H2-RA.
METHODS: The healing of deep gastric ulcers treated with PPI (n = 11) or H2-RA (n = 13) was evaluated with endoscopic ultrasonography (EUS). Every 2 weeks during treatment EUS variables such as the width and the depth of the ulcer crater, the thickness and size of the low echoic area of the ulcer base, and the distance of the disrupted muscularis propria were measured. The contraction rates of EUS variables, the ratios of the contraction rate of the depth to that of the width of the ulcer crater (D/W ratio) and the contraction rate of the distance of the disrupted muscularis propria layer to that of the width of the ulcer crater (Dm/W ratio) were calculated.
RESULTS: Only at week 2 were the D/W ratio and Dm/W ratio significantly higher in the group receiving PPI (D/W ratio, 1.79 +/- 0.701; Dm/W ratio, 0.938 +/- 0.207) than in the group receiving H2-RA (D/W ratio, 1.10 +/- 0.559; Dm/W ratio, 0.641 +/- 0.166).
CONCLUSION: This study demonstrated that PPI therapy is associated with more rapid and stronger healing than obtained with H2-RA during the early treatment period.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7886404     DOI: 10.3109/00365529409094901

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

1.  Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.

Authors:  Jian-Min Si; Qian Cao; Jia-Guo Wu
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

Review 2.  Switching between intravenous and oral pantoprazole.

Authors:  J R Pisegna
Journal:  J Clin Gastroenterol       Date:  2001-01       Impact factor: 3.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.